COVID-19 Resources

COVID-19 Q&A: Dr. Debra Kaysen on Individual and Collective Stress & Grief

The COVID-19 global pandemic is not the first event –good or bad -- to be shared by the entire world, but in this age of technology and social connection when information travels the earth at lightning speed, we are all living the full impact of this collective experience, in real time. The countless individual tragedies of the virus come together in a cumulative and mutual loss to which few of us are immune. In this Q&A, Dr. Debra Kaysen, Professor of Psychiatry and Behavioral Sciences with the Public Mental Health & Population Sciences Division, helps us better understand our communal grief and how to deal with the societal stress of COVID-19. Dr. Kaysen specializes in the treatment of trauma and PTSD and is the President of the International Society for Traumatic Stress Studies (ISTSS).

COVID-19 Q&A: Dr. Elias Aboujaoude on Technology Behaviors

Technology has been a lifeline during the COVID-19 pandemic. It’s given many the ability to work and learn from home, continue to get medical care, and share face-to-face time with family and friends despite physical distancing and stay-at-home orders…not to mention shopping, and a constant flow of information. While these have been enriching and, in some cases, life-saving aspects to our heightened connectivity during the pandemic, potentially problematic relationships with technology have also been brought into stark relief. Our expert on these matters when it comes to mental health is Dr. Elias Aboujaoude, Clinical Professor, Chief of the Anxiety Disorders Section, and Director of the OCD Clinic and the Impulse Control Disorders Clinic. One of his specialties is the intersection of technology and psychology.

COVID-19 Q&A: Dr. Elizabeth Reichert on Depression, Anxiety, Risk for Suicide

It’s no surprise that a global pandemic would exacerbate feelings of stress and fear. What is needed is understanding of how to manage those feelings, how to recognize symptoms of clinical depression and anxiety, as well as when, how, and where to get help. Dr. Elizabeth Reichert provides this expertise as clinical assistant professor of Stanford Psychiatry and Behavioral Sciences, and Director of the Pediatric Anxiety and Traumatic Stress Clinic.

COVID-19 Q&A: Dr. Kim Bullock on Therapy via Virtual Reality

With person-to-person gatherings suspended because of the Coronavirus pandemic, technology has become the lifeline for friends, family, businesses, and care providers. But even before telehealth was in the spotlight, some health professionals were utilizing the unique characteristics of Virtual Reality (VR) to deliver, and enhance, treatments. Dr. Kim Bullock, Clinical Professor of Psychiatry and Behavioral Sciences, is one of those pioneering doctors who embraced VR early on. In this Q&A, she elaborates on how it can offer particular relief for those suffering under the stress of COVID-19.

COVID-19 Q&A: Dr. Lawrence Fung on Impacts on the Neurodiverse Community

As scientists learn more about the novel Coronavirus, the consensus is that even with more effective treatments and possible vaccines, COVID-19 will likely be with us for a long time to come. New ways of working and learning will continue to evolve, and the many varieties of talents and skills will need to be accommodated for full inclusion. That includes the neurodiverse community. For this insight we turn to Dr. Lawrence Fung, Director of the Stanford Neurodiversity Project (SNP), and the Adult Neurodevelopment Clinic, as well as Assistant Professor of Psychiatry and Behavioral Sciences.

COVID-19 Q&A: Dr. Anna Lembke on Addiction

We’re seeing some signs that substance abuse and addiction is on the rise because of the stressors brought on by the COVID-19 pandemic. Dr. Anna Lembke, Associate Professor of Psychiatry and Behavioral Sciences and Medical Director of Addiction Medicine, is a national leader in the move to “bring addiction into the house of medicine” so it can be treated like any other disease. As Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, Dr. Lembke is uniquely experienced to discuss this social consequence of COVID-19.

COVID-19 Q&A: Dr. Rachel Manber on Sleep Disturbances

Stay-at-home orders have our daily routines in flux, and uncertainty and fear are constant companions in this global pandemic. As part of our COVID-19 Q&A series, Rachel Manber, Professor of Psychiatry and Behavioral Sciences and Director of the Stanford Sleep Health and Insomnia Program (SHIP), discusses how these conditions can interfere with healthy sleep or exacerbate existing sleep condition, as well as ways to get help.

COVID-19 Q&A: Dr. Hans Steiner on Anger and Aggression

The Coronavirus pandemic, with its extreme disruption of normal daily life and uncertainty for the future, compounded by several other crises (economic distress, racial tension, social inequities, political and ideological conflicts) puts us all to the test: we find ourselves immersed in a pool of negative emotions: fear, sadness, contempt, and yes, anger. What do we do with this forceful emotion, calling us to act on our behalf? Can it be managed to limit disruption to our well-being, or harnessed for a positive outcome? This obviously depends on our age. But generally, the answer is an emphatic “yes”: Anger should be one of our adaptive tools to deal with the most difficult circumstances. Sometimes it becomes an obstacle to our struggles, especially when it derails into aggression and even violence. But far more often, it energizes and motivates us to fix what is broken.

COVID-19 Q&A: Dr. James Lock on Eating Disorders

Mental health conditions can be exacerbated because of the additional pressures brought on by the Coronavirus pandemic. In this COVID-19 Q&A with Dr. Lock, a Professor of Psychiatry and Behavioral Sciences and Director of the Stanford Child and Adolescent Eating Disorder Program, we focus on how eating disorders may be further triggered by the conditions imposed by COVID-19 safety measures.

COVID-19 Q&A: Dr. Margo Thienemann on OCD

The prolonged uncertainty brought on by the Coronavirus pandemic has heightened the challenge of maintaining mental wellbeing, particularly for some with conditions that manifest in controlling outcomes, like Obsessive-Compulsive Disorder, or OCD. As part of our COVID-19 Q&A series, Dr. Margo Thienemann, Clinical Professor in the Department of Psychiatry & Behavioral Sciences and Director of Psychiatric Services at the Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) Clinic, shares how COVID-19 is impacting patients and ways to cope.

Scholarly Articles

  1. Academic Medicine in the Time of COVID-19. Roberts L. W. (2020). Academic medicine : journal of the Association of American Medical Colleges, 95(8), 1123–1124. https://doi.org/10.1097/ACM.0000000000003500

  2. COVID-19 Takes Adolescent Suicide Prevention to Less Charted Territory. Szlyk, H. S., Berk, M., Peralta, A. O., & Miranda, R. (2020). The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 67(2), 161–163. 

  3. Caring for Caregivers during COVID-19. Dang S, Penney LS, Trivedi R, Noel PH, Pugh MJ, Finley E, Pugh JA, Van Houtven CH, Leykum L. J Am Geriatr Soc. 2020 Jul 7. doi: 10.1111/jgs.16726.PMID: 32638348

  4. Coronavirus Disease 2019 Takes Adolescent Suicide Prevention to Less Charted Territory. Szlyk HS, Berk M, Peralta AO, Miranda R. J Adolesc Health. 2020 Jun 11. pii: S1054-139X(20)30302-5. doi: 10.1016/j.jadohealth.2020.05.046.

  5. Family-based treatment via videoconference: Clinical recommendations for treatment providers during COVID-19 and beyond. Matheson BE, Bohon C, Lock J. Int J Eat Disord. 2020 Jun 13. doi: 10.1002/eat.23326.

  6. Discussing substance use with clients during the COVID-19 pandemic: A motivational interviewing approach. Walker DD, Jaffe AE, Pierce AR, Walton TO, Kaysen DL. Psychol Trauma. 2020 Jun 11. doi: 10.1037/tra0000764.

  7. Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Marsden J, Darke S, Hall W, Hickman M, Holmes J, Humphreys K, Neale J, Tucker J, West R. Addiction. 2020 Jun;115(6):1007-1010. doi: 10.1111/add.15080.

  8. How Support of Early Career Researchers Can Reset Science in the Post-COVID19 World. Gibson EM, Bennett FC, Gillespie SM, et al. Cell. 2020;S0092-8674(20)30678-4. doi:10.1016/j.cell.2020.05.045

  9. Cognitive Processing Therapy for Posttraumatic Stress Disorder via Telehealth: Practical Considerations During the COVID-19 Pandemic. Moring JC, Dondanville KA, Fina BA, Hassija C, Chard K, Monson C, LoSavio ST, Wells SY, Morland LA, Kaysen D, Galovski TE, Resick PA. J Trauma Stress. 2020 May 13. doi: 10.1002/jts.22544.

  10. The impact of COVID-19 on mental health: The interactive roles of brain biotypes and human connection. Hagerty SL, Williams LM. Brain Behav Immun Health. 2020 May 7:100078. doi: 10.1016/j.bbih.2020.100078.PMID: 32382727

  11. Increased Risk of Suicide Due to Economic and Social Impacts of Social Distancing Measures to Address the Covid-19 Pandemic: A Forecast. Weems C, Carrion V, McCurdy B, Scozzafava M. (2020). 10.13140/RG.2.2.21601.45926.

  12. Chatbots in the fight against the COVID-19 pandemic. Miner AS, Laranjo L, Kocaballi AB. NPJ Digit Med. 2020 May 4;3:65. doi: 10.1038/s41746-020-0280-0. eCollection 2020. PMID: 32377576

  13. Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic. Shanafelt T, Ripp J, Trockel M. JAMA. 2020 Apr 7. doi: 10.1001/jama.2020.5893. PMID: 32259193

  14. Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Marsden J, Darke S, Hall W, Hickman M, Holmes J, Humphreys K, Neale J, Tucker J, West R. Addiction. 2020 Apr 6. doi: 10.1111/add.15080. PMID: 32250482